Eptazocine

This classification denotes an analgesic agent with the molecular formula C15H21NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2208ZLI77S, chemically known as 1,6-methano-1h-4-benzazonin-10-ol, 2,3,4,5,6,7-hexahydro-1,4-dimethyl-, (1s)- but generally known as eptazocine, which bears US NIH Compound Identifier 3246. European Medicines Agency schedules Eptazocine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06594MIG. The term EPTAZOCINE is an International Non-Proprietary Name. EPTAZOCINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eptazocine under HS 29339930 and SITC 51577. As of Q4 2014, EPTAZOCINE remains the US FDA Preferred Term for this commodity. Eptazocine bears US NLM identifiers UMLS ID C0059489 and NCI Concept Code C72115. SMILES: OC1CC2C3(CC(CC2CC1)CN(CC3)C)C.